Reduced full-field electroretinogram (ERG) in a patient treated with methotrexate

Acta Ophthalmologica Scandinavica

Volumn 82, Issue 1, 2004, Pages 96-99

  Ponjavic, Vesna ^a   Gränse, Lotta ^a   Stigmar, Elisabeth Bengtsson ^a   Andréasson, Sten ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Drug side effects; Full field electroretinography; Methotrexate; Retinal dysfunction

Indexed keywords

CHLOROQUINE; METHOTREXATE; NAPROXEN; STEROID; THIORIDAZINE;

ADOLESCENT; ARTICLE; B WAVE; BLEPHARITIS; CARDIOMYOPATHY; CASE REPORT; CONJUNCTIVITIS; DEVICE; DRUG WITHDRAWAL; ELECTROOCULOGRAPHY; ELECTROPHYSIOLOGY; ELECTRORETINOGRAM; ELECTRORETINOGRAPHY; EYE BURNING; EYE DISEASE; EYE PAIN; EYE PHOTOGRAPHY; HUMAN; MALE; OPHTHALMOSCOPY; PERIMETRY; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RETINA CONE; RETINA DISEASE; RETINA ROD; VISUAL ACUITY; VISUAL FIELD; VISUAL FIELD DEFECT; VISUAL IMPAIRMENT; VISUAL SYSTEM EXAMINATION;

ADOLESCENT; ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; ELECTROOCULOGRAPHY; ELECTRORETINOGRAPHY; HUMANS; MALE; METHOTREXATE; PHOTIC STIMULATION; PHOTORECEPTORS, VERTEBRATE; RETINAL DISEASES; VISUAL ACUITY;

EID: 1242275323     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1600-0420.2003.00181.x     Document Type: Article

References (19)

1. Andréasson S, Ponjavic V, Abrahamson M, Ehinger B, Wu W, Fujita R, Buraczynska M, Swaroop A (1997): Phenotypes in three Swedish families with X-linked retinitis pigmentosa caused by different mutations in the RPGR gene. Am J Ophthalmol 124: 95-102.
2. Bearse MA & Sutter EE (1996): Imaging localized retinal dysfunction with the multifocal electroretinogram. J Opt Soc Am A 13: 634-640.
3. Bernstein H & Ginsberg J (1964): The pathology of chloroquine retinopathy. Arch Ophthalmol 71: 146-153.
4. Davidorf FH (1973): Thioridazine pigmentary retinopathy. Arch Ophthalmol 90: 251-255.
5. Fishburne BC, Wilson DJ, Rosenbaum JT, Neuwelt EA (1997): Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma. Arch Ophthalmol 115: 1152-1156.
6. Fraunfelder FT & Meyer SM (1989): Drug-Induced Ocular Side Effects and their Drug Interactions. 3rd edn. Philadelphia: Lea & Febiger.
7. Grant WM (1986): Toxicology of the Eye. 3rd edn. Springfield, Illinois: Charles C Thomas.
8. Henkind P, Carr R, Siegel I (1954): Early chloroquine retinopathy: clinical and functional findings. Arch Ophthalmol 71: 157.
9. Hobbs HE, Sorsky A, Freedman A (1959): Retinopathy following chloroquine therapy. Lancet 2: 478-480.
10. Imperia PS, Lazarus HM, Lass JH (1989): Ocular complications of systemic cancer chemotherapy. Surv Ophthalmol 34: 209.
11. Millay RH, Klein ML, Shults WT, Dahlborg SA, Neuwelt EA (1986): Maculopathy associated with combination chemotherapy and osmotic opening of the blood-brain barrier. Am J Ophthalmol 102: 626-632.
12. Novack GD (1997): Ocular toxicology. Curr Opin Ophthalmol 8: 88-92.
13. Oshika T (1995): Ocular adverse effects of neuropsychiatric agents. Incidence Manage Drug Safety 12: 256-263.
14. Pavan-Langston D & Dunkel EC (1991): Handbook of Ocular Drug Therapy and Ocular Side Effects of the Systemic Drugs. Boston: Little, Brown.
15. Soukasian SK & Raizman MB (2000): Ocular toxicity of systemic medications. In: Albert DM & Jacobiec FA, (eds). Principles and Practise of Ophthalmology. Philadelphia: W B Saunders Co. 455-468.
16. Sutter EE & Tran D (1992): The field topography of ERG components in man. I. The photopic luminance response. Vision Res 32: 433-446.
17. Tekell JL, Silva JA, Maas JA, Bowden CL, Starck T (1996): Thioridazine-induced retinopathy. Am J Psychiatry 153: 1234-1235.
18. Velez G, Boldt HC, Whitcup SM, Nussenblatt RB, Robinson MR (2002): Local methotrexate and dexamethasone phosphate for the treatment of recurrent primary intraocular lymphoma. Ophthalmic Surg Lasers 33: 329-333.
19. Velez G, Yuan P, Sung C, Tansey G, Reed GF, Chan CC, Nussenblatt RB, Robinson MR (2001): Pharmacokinetics and toxicity of intravitreal chemotherapy for primary intraocular lymphoma. Arch Ophthalmol 119: 1518-1524.